Antenatal corticosteroids: A risk factor for the development of chronic disease

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  Asztalos, Elizabeth ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 84870926731     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/930591     Document Type: Article

References (107)

1. Silveira P. P., Portella A. K., Goldani M. Z., Barbieri M. A., Developmental origins of health and disease (DOHaD). Jornal de Pediatria 2007 83 6 494 504 2-s2.0-37149011237 10.2223/JPED.1728 (Pubitemid 350261386)
2. Waterland R. A., Michels K. B., Epigenetic epidemiology of the developmental origins hypothesis. Annual Review of Nutrition 2007 27 363 388 2-s2.0-35548941189 10.1146/annurev.nutr.27.061406.093705 (Pubitemid 351373362)
3. Wadhwa P. D., Buss C., Entringer S., Swanson J. M., Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Seminars in Reproductive Medicine 2009 27 5 358 368 2-s2.0-69349095789 10.1055/s-0029-1237424
4. Barker D., Human growth and cardiovascular disease. Nestle Nutrition Workshop Series: Pediatric Program 2008 61 21 33 2-s2.0-42449151264 10.1159/000113163
5. Barker D. J. P., In utero programming of chronic disease. Clinical Science 1998 95 2 115 128 2-s2.0-0031661215 (Pubitemid 28401260)
6. Barker D. J. P., Osmond C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. The Lancet 1986 1 8489 1077 1081 2-s2.0-0022621648 (Pubitemid 16106274)
7. Osmond C., Barker D. J. P., Winter P. D., Fall C. H. D., Simmonds S. J., Early growth and death from cardiovascular disease in women. British Medical Journal 1993 307 6918 1519 1524 2-s2.0-0027484614 (Pubitemid 23357224)
8. Barker D. J. P., Martyn C. N., Osmond C., Hales C. N., Fall C. H. D., Growth in utero and serum cholesterol concentrations in adult life. British Medical Journal 1993 307 6918 1524 1527 2-s2.0-0027331339
9. Hales C. N., Barker D. J. P., Clark P. M. S., Cox L. J., Fall C., Osmond C., Winter P. D., Fetal and infant growth and impaired glucose tolerance at age 64. British Medical Journal 1991 303 6809 1019 1022 2-s2.0-0026008824
10. Law C. M., Shiell A. W., Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. Journal of Hypertension 1996 14 8 935 941 2-s2.0-0029843771 (Pubitemid 26306057)
11. Rich-Edwards J. W., Stampfer M. J., Manson J. E., Rosner B., Hankinson S. E., Colditz G. A., Willett W. C., Hennekens C. H., Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. British Medical Journal 1997 315 7105 396 400 2-s2.0-0030786426 (Pubitemid 27346039)
12. McMillen I. C., Robinson J. S., Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 2005 85 2 571 633 2-s2.0-15544369982 10.1152/physrev.00053.2003 (Pubitemid 40404637)
13. Sapolsky R. M., Romero L. M., Munck A. U., How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 2000 21 1 55 89 2-s2.0-0034454682 10.1210/er.21.1.55 (Pubitemid 32266068)
14. Charmandari E., Kino T., Souvatzoglou E., Chrousos G. P., Pediatric stress: hormonal mediators and human development. Hormone Research 2003 59 4 161 179 2-s2.0-0037233685 10.1159/000069325 (Pubitemid 36358205)
15. Dobbing J., Sands J., Comparative aspects of the brain growth spurt. Early Human Development 1979 3 1 79 83 2-s2.0-0018372689 (Pubitemid 9141710)
16. Matthews S. G., Early programming of the hypothalamic-pituitary-adrenal axis. Trends in Endocrinology & Metabolism 2002 13 373 380
17. Seckl J. R., Glucocorticoids, feto-placental 11 β -hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997 62 1 89 94 2-s2.0-0031030590 10.1016/S0039-128X(96)00165-1 (Pubitemid 27066990)
18. Venihaki M., Carrigan A., Dikkes P., Majzoub J. A., Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proceedings of the National Academy of Sciences of the United States of America 2000 97 13 7336 7341 2-s2.0-0034691133 10.1073/pnas.97.13.7336 (Pubitemid 30431464)
19. Benediktsson R., Calder A. A., Edwards C. R. W., Seckl J. R., Placental 11 β -hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clinical Endocrinology 1997 46 2 161 166 2-s2.0-0030940457 (Pubitemid 27122161)
20. Brown R. W., Diaz R., Robson A. C., Kotelevtsev Y. V., Mullins J. J., Kaufman M. H., Seckl J. R., The ontogeny of 11 β -hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 1996 137 2 794 797 2-s2.0-0029670919 10.1210/en.137.2.794
21. McTernan C. L., Draper N., Nicholson H., Chalder S. M., Driver P., Hewison M., Kilby M. D., Stewart P. M., p.m.stewart@bham.ac.uk Reduced Placental 11 β -Hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. Journal of Clinical Endocrinology and Metabolism 2001 86 10 4979 4983 10.1210/jc.86.10.4979 (Pubitemid 33020553)
22. Stewart P. M., Rogerson F. M., Mason J. I., Type 2 11 β -hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. Journal of Clinical Endocrinology and Metabolism 1995 80 3 885 890 2-s2.0-0028986997
23. Wyrwoll C. S., Seckl J. R., Holmes M. C., Altered placental function of 11 β -hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009 150 3 1287 1293 2-s2.0-67649847784 10.1210/en.2008-1100
24. Mairesse J., Lesage J., Breton C., Bréant B., Hahn T., Darnaudéry M., Dickson S. L., Seckl J., Blondeau B., Vieau D., Maccari S., maccari@univ-lille1.fr Viltart O., Maternal stress alters endocrine function of the feto-placental unit in rats. American Journal of Physiology 2007 292 6 E1526 E1533 10.1152/ajpendo.00574.2006 (Pubitemid 47084686)
25. Bertram C., c.bertram@soton.ac.uk Trowern A. R., Copin N., Jackson A. A., Whorwood C. B., The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11 β -hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 2001 142 7 2841 2853 10.1210/en.142.7.2841 (Pubitemid 32575519)
26. Langley-Evans S. C., Gardner D. S., Jackson A. A., Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. Journal of Nutrition 1996 126 6 1578 1585 2-s2.0-0029929910 (Pubitemid 26182392)
27. Sarkar S., Tsai S. W., Nguyen T. T., Plevyak M., Padbury J. F., Rubin L. P., Lewis-Rubin@brown.edu Inhibition of placental 11 β -hydroxysteroid dehydrogenase type 2 by catecholamines via α -adrenergic signaling. American Journal of Physiology 2001 281 6 50-6 R1966 R1974
28. Births 2007, Statistics Canada. Ministry of Industry, Catalogue no. 84F0210X, Ottawa 2009
29. WHO (World Health Organization), The world health report. 2005, http://www.who.int/whr/2005/en/index.html
30. Kramer M. S., Demissie K., Yang H., Platt R. W., Sauve R., Liston R., The contribution of mild and moderate preterm birth to infant mortality. Journal of the American Medical Association 2000 284 7 843 849 2-s2.0-0034675053 (Pubitemid 30643611)
31. Hack M., Fanaroff A. A., Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Human Development 1999 53 3 193 218 2-s2.0-0032890103 10.1016/S0378-3782(98)00052-8 (Pubitemid 28556879)
32. Schmidt B., Asztalos E. V., Roberts R. S., Robertson C. M. T., Sauve R. S., Whitfield M. F., Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months. Journal of the American Medical Association 2003 289 9 1124 1129 2-s2.0-0037420266 10.1001/jama.289.9.1124 (Pubitemid 37430326)
33. Saigal S., Doyle L. W., An overview of mortality and sequelae of preterm birth from infancy to adulthood. The Lancet 2008 371 9608 261 269 2-s2.0-38149116341 10.1016/S0140-6736(08)60136-1
34. Grier D. G., Halliday H. L., Effects of glucocorticoids on fetal and neonatal lung development. Treatments in Respiratory Medicine 2004 3 5 295 306 2-s2.0-11044235058 10.2165/00151829-200403050-00004 (Pubitemid 40045495)
35. Jobe A. H., Glucocorticoids, inflammation and the perinatal lung. Seminars in Neonatology 2001 6 4 331 342 2-s2.0-0035740353 10.1053/siny.2001. 0068 (Pubitemid 34586852)
36. Liggins G. C., Howie R. N., A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972 50 4 515 525 2-s2.0-0015412890
37. Crowley P., Chalmers I., Keirse M. J. N. C., The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1990 97 1 11 25 2-s2.0-0025232649 (Pubitemid 20136124)
38. National Institute of Child Health and Human Development Office of Medical Applications of Research, NIH, Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. Vol. 95-3784, NIH Publication, November 1994
39. Crane J., Armson A., Brunner M., De La Ronde S., Farine D., Keenan-Lindsay L., Leduc L., Schneider C., Van Aerde J., Antenatal corticosteroid therapy for fetal maturation. JOGC: Journal of Obstetrics and Gynaecology Canada 2003 25 1 45 52
40. McLaughlin K. J., Crowther C. A., caroline.crowther@adelaide.edu.au Walker N., Harding J. E., Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Australian and New Zealand Journal of Obstetrics and Gynaecology 2003 43 2 101 106 10.1046/j.0004-8666. 2003.00052.x (Pubitemid 36626109)
41. Committee on Obstetric Practice, ACOG committee opinion: antenatal corticoid therapy for fetal maturation. Obstetrics & Gynecology 2002 99 871 873
42. Crowther C. A., McKinlay C. J., Middleton P., Harding J. E., Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews (Online) 2011 6 CD003935
43. Peltoniemi O. M., outi.peltoniemi@mail.suomi.net Kari M. A., Hallman M., Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 2011 90 7 719 727 10.1111/j.1600-0412.2011.01132.x
44. Dalziel S. R., Lim V. K., Lambert A., McCarthy D., Parag V., Rodgers A., Harding J. E., Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. British Medical Journal 2005 331 7518 665 668 2-s2.0-25144477449 10.1136/bmj.38576.494363.E0 (Pubitemid 41374841)
45. Dalziel S. R., Walker N. K., Parag V., Mantell C., Rea H. H., Rodgers A., Harding J. E., Cardiovascular risk factors after antenatal exposure to betamethasone: 30-Year follow-up of a randomised controlled trial. The Lancet 2005 365 9474 1856 1862 2-s2.0-19744379509 10.1016/S0140-6736(05)66617-2 (Pubitemid 40744963)
46. French N. P., Hagan R., Evans S. F., Godfrey M., Newnham J. P., Repeated antenatal corticosteroids: size at birth and subsequent development. American Journal of Obstetrics and Gynecology 1999 180 1 114 121 2-s2.0-0033058095 10.1016/S0002-9378(99)70160-2 (Pubitemid 29088400)
47. Thorp J. A., jathorp@bellsouth.net O'Connor M., Belden B., Etzenhouser J., Hoffman E. L., Jones P. G., Effects of phenobarbital and multiple-dose corticosteroids on developmental outcome at age 7 years. Obstetrics and Gynecology 2003 101 2 363 373 10.1016/S0029-7844(02)02509-7 (Pubitemid 36170139)
48. French N. P., Hagan R., Evans S. F., Mullan A., Newnham J. P., Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. American Journal of Obstetrics and Gynecology 2004 190 3 588 595 2-s2.0-1642546490 10.1016/j.ajog.2003.12.016 (Pubitemid 38406764)
49. Kumar P., Seshadri R., Grobman W. A., Neurodevelopmental outcome of very low birth weight infants after multiple courses of antenatal corticosteroids. Journal of the Society for Gynecologic Investigation 2004 11 7 483 487 2-s2.0-5344255263 10.1016/j.jsgi.2004.05.006 (Pubitemid 39349201)
50. Murphy K. E., Hannah M. E., Willan A. R., Hewson S. A., Ohlsson A., Kelly E. N., Matthews S. G., Saigal S., Asztalos E., Ross S., Delisle M. F., Amankwah K., Guselle P., Gafni A., Lee S. K., Armson B. A., Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. The Lancet 2008 372 9656 2143 2151 2-s2.0-57649215365 10.1016/S0140-6736(08)61929-7
51. Crowther C. A., caroline.crowther@adelaide.edu.au Doyle L. W., Haslam R. R., Hiller J. E., Harding J. E., Robinson J. S., Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. The New England Journal of Medicine 2007 357 12 1179 1189 10.1056/NEJMoa071152 (Pubitemid 47443177)
52. Wapner R. J., Sorokin Y., Mele L., Johnson F., Dudley D. J., Spong C. Y., Peaceman A. M., Leveno K. J., Malone F., Caritis S. N., Mercer B., Harper M., Rouse D. J., Thorp J. M., Ramin S., Carpenter M. W., Gabbe S. G., Long-term outcomes after repeat doses of antenatal corticosteroids. The New England Journal of Medicine 2007 357 12 1190 1198 2-s2.0-34548833077 10.1056/NEJMoa071453 (Pubitemid 47443178)
53. Peltoniemi O. M., Kari M. A., Lano A., Yliherva A., Puosi R., Lehtonen L., Tammela O., Hallman M., Two-year follow-up of a randomised trial with repeated antenatal betamethasone. Archives of Disease in Childhood 2009 94 6 F402 F406 2-s2.0-70350447812 10.1136/adc.2008.150250
54. Asztalos E. V., Murphy K. E., Hannah M. E., Willan A. R., Matthews S. G., Ohlsson A., Kelly E. N., Saigal S., Ross S., Delisle M. F., Amankwah K., Guselle P., Gafni A., Lee S. K., Armson B. A., Sananes R., Tomat L., Multiple courses of antenatal corticosteroids for preterm birth study: 2-Year outcomes. Pediatrics 2010 126 5 e1045 e1055 2-s2.0-78049419925 10.1542/peds.2010-0857
55. Hack M., Taylor H. G., Drotar D., Schluchter M., Cartar L., Wilson-Costello D., Klein N., Friedman H., Mercuri-Minich N., Morrow M., Poor predictive validity of the Bayley Scales of infant development for cognitive function of extremely low birth weight children at school age. Pediatrics 2005 116 2 333 341 2-s2.0-33644613511 10.1542/peds.2005-0173 (Pubitemid 44161457)
56. Crowther C. A., Doyle L. W., Anderson P., Repeat dose(s) of prenatal corticosteroids for women at risk of preterm birth: early school-age outcomes (6 to-8 years) for the ACTORDS trial. E-PAS2011:3123.6
57. Korte S. M., Corticosteroids in relation to fear, anxiety and psychopathology. Neuroscience and Biobehavioral Reviews 2001 25 2 117 142 2-s2.0-0035032992 10.1016/S0149-7634(01)00002-1 (Pubitemid 32377167)
58. Meaney M. J., Diorio J., Francis D., Widdowson J., LaPlante P., Caldji C., Sharma S., Seckl J. R., Plotsky P. M., Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Developmental Neuroscience 1996 18 1-2 49 72 2-s2.0-0030038741 (Pubitemid 26257908)
59. Andrews M. H., Matthews S. G., Regulation of glucocorticoid receptor mRNA and heat shock protein 70 mRNA in the developing sheep brain. Brain Research 2000 878 1-2 174 182 2-s2.0-0034730445 10.1016/S0006-8993(00)02735-9
60. Matthews S. G., Antenatal glucocorticoids and programming of the developing CNS. Pediatric Research 2000 47 3 291 300 2-s2.0-0034002776 (Pubitemid 30127033)
61. Brown R. W., Chapman K. E., Kotelevtsev Y., Yau J. L. W., Lindsay R. S., Brett L., Leckie C., Murad P., Lyons V., Mullins J. J., Edwards C. R. W., Seckl J. R., Cloning and production of antisera to human placental 11 β -hydroxysteroid dehydrogenase type 2. Biochemical Journal 1996 313 3 1007 1017 2-s2.0-0030031914 (Pubitemid 26050840)
62. Stewart P. M., Murry B. A., Mason J. I., Type 2 11 β -hydroxysteroid dehydrogenase in human fetal tissues. Journal of Clinical Endocrinology and Metabolism 1994 78 6 1529 1532 2-s2.0-0028179436 10.1210/jc.78.6.1529
63. Seckl J. R., Prenatal glucocorticoids and long-term programming. European Journal of Endocrinology, Supplement 2004 151 3 U49 U62 2-s2.0-10344226154 (Pubitemid 39627056)
64. Weinstock M., The long-term behavioural consequences of prenatal stress. Neuroscience and Biobehavioral Reviews 2008 32 6 1073 1086 2-s2.0-45849128326 10.1016/j.neubiorev.2008.03.002
65. Huang W. L., Beazley L. D., Quinlivan J. A., Evans S. F., Newnham J. P., Dunlop S. A., Effect of corticosteroids on brain growth in fetal sheep. Obstetrics and Gynecology 1999 94 2 213 218 2-s2.0-0032806268 10.1016/S0029-7844(99)00265-3 (Pubitemid 29352864)
66. Huang W. L., Harper C. G., Evans S. F., Newnham J. P., Dunlop S. A., Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. International Journal of Developmental Neuroscience 2001 19 5 487 493 2-s2.0-0034894557 10.1016/S0736-5748(01)00035-1 (Pubitemid 32722126)
67. Huang W. L., Harper C. G., Evans S. F., Newnham J. P., Dunlop S. A., Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. International Journal of Developmental Neuroscience 2001 19 4 415 425 2-s2.0-0034985968 10.1016/S0736-5748(01)00026-0 (Pubitemid 32500337)
68. Antonow-Schlorke I., Schwab M., Li C., Nathanielsz P. W., Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. Journal of Physiology 2003 547 1 117 123 2-s2.0-0037440753 10.1113/jphysiol.2002.025700 (Pubitemid 36285167)
69. Hayashi A., Nagaoka M., Yamada K., Ichitani Y., Miake Y., Okado N., Maternal stress induces synaptic loss and developmental disabilities of offspring. International Journal of Developmental Neuroscience 1998 16 3-4 209 216 2-s2.0-0032100242 10.1016/S0736-5748(98)00028-8 (Pubitemid 28427086)
70. Lemaire V., Koehl M., Le Moal M., Abrous D. N., Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2000 97 20 11032 11037 2-s2.0-0034718603
71. Uno H., Lohmiller L., Thieme C., Kemnitz J. W., Engle M. J., Roecker E. B., Farrell P. M., Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Developmental Brain Research 1990 53 2 157 167 2-s2.0-0025270537 10.1016/0165-3806(90)90002-G (Pubitemid 20161857)
72. Sapolsky R. M., Uno H., Rebert C. S., Finch C. E., Hippocampal damage associated with prolonged glucocorticoid exposure in primates. Journal of Neuroscience 1990 10 9 2897 2902 2-s2.0-0025485399
73. Kapoor A., Petropoulos S., Matthews S. G., Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Research Reviews 2008 57 2 586 595 2-s2.0-40749107391 10.1016/j.brainresrev.2007.06.013 (Pubitemid 351381772)
74. Harris A., Seckl J., Glucocorticoids, prenatal stress and the programming of disease. Hormones and Behavior 2010 59 279 289 2-s2.0-77953829714 10.1016/j.yhbeh.2010.06.007
75. Weinstock M., Matlina E., Maor G. I., Rosen H., McEwen B. S., Prenatal stress selectivity alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Research 1992 595 2 195 200 2-s2.0-0026613169 10.1016/0006-8993(92)91049-K
76. McCormick C. M., Smythe J. W., Sharma S., Meaney M. J., Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Developmental Brain Research 1995 84 1 55 61 2-s2.0-0028820942 10.1016/0165-3806(94)00153-Q
77. Owen D., Matthews S. G., Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs. Journal of Physiology 2007 578 1 249 257 2-s2.0-33845797457 10.1113/jphysiol.2006.122887 (Pubitemid 44971122)
78. Setiawan E., Jackson M. F., Macdonald J. F., Matthews S. G., Effects of repeated prenatal glucocorticoid exposure on long-term potentiation in the juvenile guinea-pig hippocampus. Journal of Physiology 2007 581 3 1033 1042 2-s2.0-34250016794 10.1113/jphysiol.2006.127381 (Pubitemid 46887979)
79. Uno H., Eisele S., Sakai A., Shelton S., Baker E., DeJesus O., Holden J., Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavior 1994 28 4 336 348 2-s2.0-0028567422 10.1006/hbeh.1994.1030
80. de Vries A., Holmes M. C., Heijnis A., Seier J. V., Heerden J., Louw J., Wolfe-Coote S., Meaney M. J., Levitt N. S., Seckl J. R., Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. Journal of Clinical Investigation 2007 117 4 1058 1067 2-s2.0-34147141449 10.1172/JCI30982 (Pubitemid 46556762)
81. Matthews S. G., Foetal experience: lifelong consequences. Journal of Neuroendocrinology 2007 19 1 73 74 2-s2.0-33845273836 10.1111/j.1365-2826.2006. 01504.x (Pubitemid 44857734)
82. Weaver I. C. G., Cervoni N., Champagne F. A., D'Alessio A. C., Sharma S., Seckl J. R., Dymov S., Szyf M., Meaney M. J., Epigenetic programming by maternal behavior. Nature Neuroscience 2004 7 8 847 854 2-s2.0-3342989681 10.1038/nn1276 (Pubitemid 38989508)
83. Weaver I. C. G., Szyf M., Meaney M. J., From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocrine Research 2002 28 4 699 2-s2.0-0036932871 10.1081/ERC-120016989 (Pubitemid 36042539)
84. Meaney M. J., Szyf M., Maternal care as a model for experience-dependent chromatin plasticity? Trends in Neurosciences 2005 28 9 456 463 2-s2.0-23944441386 10.1016/j.tins.2005.07.006 (Pubitemid 41187794)
85. Szyf M., Weaver I. C. G., Champagne F. A., Diorio J., Meaney M. J., Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Frontiers in Neuroendocrinology 2005 26 3-4 139 162 2-s2.0-28844440383 10.1016/j.yfrne.2005.10.002 (Pubitemid 41772652)
86. Weaver I. C. G., Champagne F. A., Brown S. E., Dymov S., Sharma S., Meaney M. J., Szyf M., Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. Journal of Neuroscience 2005 25 47 11045 11054 2-s2.0-28044436691 10.1523/JNEUROSCI.3652-05.2005 (Pubitemid 41692634)
87. Weaver I. C. G., Diorio J., Seckl J. R., Szyf M., Meaney M. J., Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Annals of the New York Academy of Sciences 2004 1024 182 212 2-s2.0-3042747515 10.1196/annals.1321.099 (Pubitemid 38879602)
88. Klose R. J., Bird A. P., Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences 2006 31 2 89 97 2-s2.0-32344450824 10.1016/j.tibs.2005.12.008 (Pubitemid 43221841)
89. Newell-Price J., Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond. Journal of Endocrinology 2003 177 3 365 372 2-s2.0-0037701826 10.1677/joe.0.1770365 (Pubitemid 36722291)
90. Abdolmaleky H. M., Cheng K. H., Faraone S. V., Wilcox M., Glatt S. J., Gao F., Smith C. L., Shafa R., Aeali B., Carnevale J., Pan H., Papageorgis P., Ponte J. F., Sivaraman V., Tsuang M. T., Thiagalingam S., Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics 2006 15 21 3132 3145 2-s2.0-33750244045 10.1093/hmg/ddl253 (Pubitemid 44607800)
91. Alikhani-Koopaei R., Fouladkou F., Frey F. J., Frey B. M., Epigentic regulation of 11 β -hydroxysteroid dehydrogenase type 2 expression. Journal of Clinical Investigation 2004 114 8 1146 1157 2-s2.0-9644252865 10.1172/JCI200421647 (Pubitemid 39578704)
92. Mueller B. R., Bale T. L., Sex-specific programming of offspring emotionality after stress early in pregnancy. Journal of Neuroscience 2008 28 36 9055 9065 2-s2.0-54049086269 10.1523/JNEUROSCI.1424-08.2008
93. Oberlander T. F., Weinberg J., Papsdorf M., Grunau R., Misri S., Devlin A. M., Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008 3 2 97 106 2-s2.0-47149100122
94. McGowan P. O., Sasaki A., D'Alessio A. C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M. J., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience 2009 12 3 342 348 2-s2.0-60749105468 10.1038/nn.2270
95. Burdge G. C., Hanson M. A., Slater-Jefferies J. L., Lillycrop K. A., Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? British Journal of Nutrition 2007 97 6 1036 1046 2-s2.0-34247469154 10.1017/S0007114507682920 (Pubitemid 46925352)
96. 2 generations. British Journal of Nutrition 2007 97 3 435 439 2-s2.0-34047258298 10.1017/S0007114507352392 (Pubitemid 46662031)
97. Lillycrop K. A., Phillips E. S., Jackson A. A., Hanson M. A., Burdge G. C., Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition 2005 135 6 1382 1386 2-s2.0-20444411948 (Pubitemid 40799599)
98. Lillycrop K. A., Slater-Jefferies J. L., Hanson M. A., Godfrey K. M., Jackson A. A., Burdge G. C., Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. British Journal of Nutrition 2007 97 6 1064 1073 2-s2.0-34247514180 10.1017/S000711450769196X (Pubitemid 46925358)
99. Champagne F. A., Weaver I. C. G., Diorio J., Dymov S., Szyf M., Meaney M. J., Maternal care associated with methylation of the estrogen receptor- α 1b promoter and estrogen receptor- α expression in the medial preoptic area of female offspring. Endocrinology 2006 147 6 2909 2915 2-s2.0-33646784653 10.1210/en.2005-1119 (Pubitemid 43764626)
100. Thomassin H., Flavin M., Espinas M. L., Grange T, Glucocorticoid-induced DNA demethylation andgene memory during development. The EMBO Journal 2001 20 1974 1983 (Pubitemid 32397399)
101. Terzolo M., Allasino B., Bosio S., Brusa E., Daffara F., Ventura M., Aroasio E., Sacchetto G., Reimondo G., Angeli A., Camaschella C., Hyperhomocysteinemia in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 8 3745 3751 2-s2.0-4043175422 10.1210/jc.2004-0079 (Pubitemid 39071467)
102. James S. J., Melnyk S., Pogribna M., Pogribny I. P., Caudill M. A., Elevation in S-Adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. Journal of Nutrition 2002 132 8 2361S 2366S 2-s2.0-0036326660 (Pubitemid 34848108)
103. Drake A. J., mandy.drake@ed.ac.uk Walker B. R., Seckl J. R., Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. American Journal of Physiology 2005 288 1 R34 R38 10.1152/ajpregu.00106.2004 (Pubitemid 40023908)
104. Schmitz T., Antenatal corticosteroids: neonatal effects of a second course. Archives de Pediatrie 2010 17 3 S101 S104 2-s2.0-77955893586 10.1016/S0929-693X(10)70908-8
105. Peltoniemi O. M., Kari M. A., Tammela O., Lehtonen L., Marttila R., Halmesmäki E., Jouppila P., Hallman M., mhallman@cc.oulu.fi Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth. Pediatrics 2007 119 2 290 298 10.1542/peds.2006-1549 (Pubitemid 46397753)
106. Garite T. J., Kurtzman J., Maurel K., Clark R., Impact of a "rescue course" of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. American Journal of Obstetrics and Gynecology 2009 200 3 248.e1 248.e9 10.1016/j.ajog.2009.01.021
107. Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G., Vannier M. W., Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America 1996 93 9 3908 3913 2-s2.0-0029862949 10.1073/pnas.93.9.3908 (Pubitemid 26144221)